Equitron Medica Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 5.15 M
as on 23-10-2024
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.00 Cr
as on 23-10-2024
- Satisfied Charges ₹ 1.25 Cr
as on 23-10-2024
- Revenue 9.81%
(FY 2023)
- Profit 6.46%
(FY 2023)
- Ebitda -22.94%
(FY 2023)
- Net Worth 39.76%
(FY 2023)
- Total Assets -0.69%
(FY 2023)
About Equitron Medica
The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.15 M.
The company currently has active open charges totaling ₹7.00 Cr. The company has closed loans amounting to ₹1.25 Cr, as per Ministry of Corporate Affairs (MCA) records.
Hemant Shah, Pallavi Shah, Sagar Shah, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999MH2018PTC303609
- Company No.
303609
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jan 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Equitron Medica Private Limited offer?
Equitron Medica Private Limited offers a wide range of products and services, including Plastic & Glass Labware, Test Tubes, Laboratory Glassware, Laboratory & Lab Equipment, Distilling Apparatus, Laboratory Plasticware, Laboratory Bath, Laboratory Consumables, Lab Incubator, Process Pumps.
Who are the key members and board of directors at Equitron Medica?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hemant Shah  | Managing Director | 03-Jan-2018 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pallavi Shah | Whole-Time Director | 03-Jan-2018 | Current |
| Sagar Shah | Whole-Time Director | 03-Jan-2018 | Current |
| Sachin Shetye | Whole-Time Director | 02-Apr-2018 | Current |
Financial Performance of Equitron Medica.
Equitron Medica Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.81% increase. The company also saw a slight improvement in profitability, with a 6.46% increase in profit. The company's net worth Soared by an impressive increase of 39.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Equitron Medica?
In 2022, Equitron Medica had a promoter holding of 96.72% and a public holding of 3.28%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 Dec 2018 | ₹7.00 Cr | Open |
Tjsb Sahakari Bank Limited Creation Date: 05 Jan 2019 | ₹1.04 M | Satisfied |
Tjsb Sahakari Bank Limited Creation Date: 03 Jan 2018 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Equitron Medica?
Unlock and access historical data on people associated with Equitron Medica, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Equitron Medica, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Equitron Medica's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
